Register Login

Revolution Medicines Inc (RVMD)

Anders Jack 🟡 adjusted position in 10.0K shares (4 derivative) of Revolution Medicines, Inc. (RVMD) at $40.17 Transaction Date: Sep 02, 2025 | Filing ID: 000326

Full text
Register to leave comments
  • News bot Sept. 4, 2025, 11:07 p.m.

    🔍 Anders Jack (Executive)

    Company: Revolution Medicines, Inc. (RVMD)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 4
    • Holdings reported: 0
    • Total shares acquired: 10,000
    • Total shares sold: 20,000

    Detailed Transactions and Holdings:

    • Acquired 2,814 shares of Common Stock at $2.68 per share (Direct)
      Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 116,128.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 1,948 shares of Common Stock at $4.73 per share (Direct)
      Date: 2025-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 118,076.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 4,762 shares of Common Stock at $40.0168 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,314.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
    • Acquired 3,189 shares of Common Stock at $4.73 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 116,503.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 2,049 shares of Common Stock at $17.0 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 118,552.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 5,238 shares of Common Stock at $40.1742 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,314.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
    • Sold 2,814 shares of Stock Option (Right to Buy) at $2.68 per share (Derivative)
      Date: 2025-09-02 | Code: M | Expires: 2028-09-26 | Exercise: 2022-08-16 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,948 shares of Stock Option (Right to Buy) at $4.73 per share (Derivative)
      Date: 2025-09-02 | Code: M | Expires: 2029-08-08 | Exercise: 2023-08-09 | equity_swap_involved: 0 | shares_owned_after: 3,189.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,189 shares of Stock Option (Right to Buy) at $4.73 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2029-08-08 | Exercise: 2023-08-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,049 shares of Stock Option (Right to Buy) at $17.0 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2030-02-11 | Exercise: 2024-02-12 | equity_swap_involved: 0 | shares_owned_after: 15,418.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
    • F2: Includes 54,213 RSUs.
    • F3: This transaction was executed in multiple trades in prices ranging from $40.00 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    • F4: This transaction was executed in multiple trades in prices ranging from $40.01 to $40.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Search

News categories